This is a promotional presentation from Pfizer. LYRICA
®
is licensed for the treatment of generalised anxiety disorder (GAD) in adults.
Contact Us
Your returning patients with depression may also have Generalised Anxiety Disorder (GAD)
1
On average, how many times a year does a patient with depression and GAD visit their doctor?
2
1 in 6 patients with MDD are suffering from GAD. What impact does this have?
3
Patients may present with several different symptoms. What percentage of patients with GAD do you think present with anxiety?
4
Experience the GAD-2 screening tool
5
What percentage of patients with GAD have an inadequate response to SSRIs/SNRIs and CBT?
6
Why use LYRICA
®
as an add-on therapy?
7
Screen your returning patients with depression for GAD. Consider LYRICA
®
as add-on therapy for those patients who are diagnosed with GAD
8
Feedback
Hello
Close
Tell me more